Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT04258813 Recruiting - Hypertension Clinical Trials

Onco-primary Care Networking to Support TEAM-based Care

ONE TEAM
Start date: June 14, 2021
Phase: N/A
Study type: Interventional

The proposed ONE TEAM Study is an 18-month, cluster randomized controlled trial. This study will use a sequential multiple assignment randomized trial (SMART) design with a second randomization for the intervention group using a dynamic treatment regimen approach. The investigators propose to randomize 800 adults with newly-diagnosed selected cancers treated with curative intent (breast, prostate, colorectal, endometrial, non-small cell lung, and endometrial) and with >1 selected cardiovascular disease (CVD) comorbidity (hypertension, type 2 diabetes mellitus, hypercholesterolemia). Participants will be enrolled through Duke Cancer Institute and two community-based oncology practices, both settings serving socio-demographically diverse populations. The unit of randomization will be the PCP clinic; there will be ~80 PCP clinics across North Carolina involved in the study. The overarching goals of this study are to improve chronic disease management and communication among cancer survivors by engaging PCPs as active members of the cancer care team and reframing the message to cancer survivors and providers. A diversity supplement with retrospective and qualitative components has been added to abstract older adults with solid tumors who underwent cancer surgery at DUHS. Aims include (1) to estimate the prevalence of cardiovascular complications ≤90 postoperative days among older adults with solid tumors undergoing surgery, and its association with care coordination between surgical providers and PCPs ; (2) to develop a risk index for cardiovascular complications ≤90 days of surgery among older adult patients with a solid tumor; and (3) to Assess experience and perceptions of PCPs on care coordination with surgical providers of older adults with a solid tumor following cancer surgery.

NCT ID: NCT04257058 Recruiting - Cancer Clinical Trials

Education Tools to Support Pediatric Survivor Care

Start date: June 7, 2022
Phase: N/A
Study type: Interventional

This study aims to evaluate the impact of electronic educational materials on adolescent and young adult ("AYA") survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.

NCT ID: NCT04256720 Recruiting - Healthy Clinical Trials

The Multi-Ethnic Lifestyle Study

MELS
Start date: December 10, 2018
Phase:
Study type: Observational [Patient Registry]

The study design is cross-sectional using a self-completion questionnaire in an English speaking multi-ethic population within Leicester and Leicestershire. The study will adopt a convenient and purposive sampling recruitment strategy across a variety of settings within Leicestershire to facilitate recruitment of a wide range of participants.

NCT ID: NCT04253678 Recruiting - Cancer Clinical Trials

Vortioxetine for Cancer Patients With Depression: An Observational Study

Start date: December 12, 2019
Phase:
Study type: Observational

The purpose of this observational antidepressant study is to determine the efficacy of vortioxetine on depression and cognitive function, and elucidate its potential effects on quality of life in patients with cancer (of any origin). We hypothesise that given its unique mechanism of action as a multimodal serotonin modulator, vortioxetine is set to achieve the above goals while maintaining a favourable side effect profile.

NCT ID: NCT04246073 Recruiting - Cancer Clinical Trials

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

Non interventional multi-centric study that will aim in evaluating the efficacy and safety of Fondaparinux in surgical cancer patients, identifying in parallel the most relevant and critical risk factors for Thromboembolism.

NCT ID: NCT04243720 Recruiting - Cancer Clinical Trials

Immune Resistance Interrogation Study

IRIS
Start date: August 26, 2020
Phase:
Study type: Observational

This is a prospective research study which will include patients who have progressed on immunotherapy as their most recent line of therapy. This study aims to characterize whether patients who fail to respond to immunotherapy versus patients who respond initially but after a period of time progress demonstrate different genomic, transcriptomic, epigenetic, immunophenotyping profiles. Patients will have a one-time fresh tumor biopsy. Serial blood samples (total amount of blood drawn may not exceed the lesser of 50 mL or 3 mL/kg in an 8 week period), archival tissue (if available) and one stool sample will be collected.

NCT ID: NCT04236154 Recruiting - Cancer Clinical Trials

"Prescribing" Exercise to Cancer Patients at High-Risk for Falls

Start date: September 3, 2020
Phase: Phase 1
Study type: Interventional

Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurious falls.

NCT ID: NCT04234646 Recruiting - Cancer Clinical Trials

Patient Navigation 2.0

Start date: December 9, 2020
Phase: N/A
Study type: Interventional

This study evaluates whether a "Patient Navigation 2.0 Checklist" intervention is effective in addressing patients' social determinants of health and recommended cancer-related screenings, behavioral counseling, and immunizations.

NCT ID: NCT04221464 Recruiting - Cancer Clinical Trials

Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

BCB
Start date: November 25, 2019
Phase: N/A
Study type: Interventional

The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.

NCT ID: NCT04218682 Recruiting - Cancer Clinical Trials

Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors

Start date: December 10, 2018
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of an interactive mobile game, Shadow's Edge, on enhancing resilience, promoting identity development, and decreasing somatic symptoms among adolescent and young adult survivors of cancer.